跳至主要内容
临床试验/NCT01667770
NCT01667770已完成不适用

Dural Graft Equivalent Comparison Trial

St. Joseph's Hospital and Medical Center, Phoenix2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2012年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
41
试验地点
2
主要终点
Complications encountered during the subject's post-operative care

研究概览

简要总结

This research study is to find out which types of dural grafts used during surgery for Chiari Malformations are superior. We believe that autologous dural grafts are superior to non-autologous grafts.

详细描述

The study compares autologous grafts vs. non-autologous grafts. Non-autologous grafts include synthetics and grafts from animals. Autologous grafts have a better side-effect profile than non-autologous grafts. We believe this improved side-effect profile will result in a decreased incidence of reoperation for post-operative infections and post-operative fluid collections (pseudomeningoceles and seromas). Study is open to all non-pregnant minor and adult subjects. Subjects must have symptomatic Chiari Malformation described as > or equal to 6mm descent of the cerebellar tonsils below the foramen magnum with accompanying headaches and/or neurologic findings (arm pain/weakness, myelopathy, etc.). After the 12-month follow-up is completed on the first 100 subjects there will be an interim analysis of the results in order to determine whether one of the treatments has a statistically superior outcome. If a statistically superior outcome is noted, the trial will stop after being reviewed by a data monitoring committee. If no statistically significant difference is seen at one year, the study will continue until the 12-month follow-up is completed on the 200th patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Minor or adult males and females
  • Symptomatic Chiari Malformation
  • Greater or equal to 6mm descent of the cerebellar tonsils below the foramen magnum
  • Headaches and/or neurologic findings (e.g., arm pain/weakness, myelopathy, etc.)

排除标准

  • Pregnancy

结局指标

主要结局

Complications encountered during the subject's post-operative care

时间窗: 2 years

After the 12-month follow-up is completed on the first 100 subjects there will be an interim analysis of the results in order to determine whether one of the treatments has a statistically superior outcome. If a statistically superior outcome is noted, the trial will stop after being reviewed by a data monitoring committee. If no statistically significant difference is seen at one year, the study will continue until the 12-month follow-up is completed on the 200th patient.

次要结局

未报告次要终点

研究者

发起方
St. Joseph's Hospital and Medical Center, Phoenix
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验